Disitamab vedotin in urothelial carcinoma patients: a clinical trial perspective from ARON working group
Year: 2026
Type: review
Authors: Concetta Calabrò, Francesco Ciccimarra, Anna Milella, Gerardo Cazzato, Mario Della Mura, Loredana Palermo, Jure Murgić, Tibor Szarvas, Kannan Sridharan, Maria Tereza Nieto-Coronel, Aly-Khan A. Lalani, Olivier Mukuku, Anas Zayed, Cinthia Gauna, Chiara Paciolla, Raffaella Massafra, Oronzo Brunetti, Veronica Mollica, Francesco Massari, Matteo Santoni, Alessandro Rizzo
Institutions: Istituto Tumori Bari, University of Bari Aldo Moro, Sisters of Charity Hospital, Semmelweis University, University of Duisburg-Essen, Arabian Gulf University, McMaster University, King Hussein Cancer Center, Instituto Nacional de Câncer - INCA, Instituto Nacional del Cáncer, University of Bologna, Ospedale di Macerata, ARON Research Foundation ETS
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7219837565